Immuneering to Present at Oppenheimer’s Private Life Sciences Company Call Series

NEXT STORY
FDA Approves American Gene Technologies (AGT) to Move Forward with Phase 1 Clinical Trial of HIV Cure Program
PREV STORY
Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Data Related to COVID-19 and Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments

RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments

Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for ...

author_avatar
NASDAQ Market News

Bavarian Nordic Completes Enrollment of First Stage in Chordoma Phase 2 Trial

COPENHAGEN, Denmark, January 25, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

author_avatar
NASDAQ Market News